NP / PA
East Tennessee Children's Hospital Primary Care Center, INC.
East Tennessee Children's Hospital Primary Care Center, INC. was paid $31.61M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoEAST TENNESSEE CHILDREN'S HOSPITAL PRIMARY CARE CENTER, INC.
KNOXVILLE, TN 37916
KNOXVILLE, TN 37916
33aNPI1235350901assigned 05/01/2007
33bProvider typePediatric Nurse Practitioner
28Total paid$31.61M
24GClaims977,818
24DCodes billed91
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Tennessee
Rank by total paid#1 of 70
Median peer was paid$60K
This provider vs. median523×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ROSENDAHL, ANDREW controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,049 | $1.09M | |
| 2019 | 122,739 | $3.30M | |
| 2020 | 110,290 | $3.23M | |
| 2021 | 155,567 | $4.80M | |
| 2022 | 169,713 | $5.52M | |
| 2023 | 212,623 | $7.38M | |
| 2024incomplete | 172,837 | $6.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 214,784 | 177,673 | $11.06M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12% | 82,567 | 75,179 | $3.71M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.6% | 38,344 | 35,818 | $3.02M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.7% | 38,334 | 33,635 | $2.76M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.0% | 34,986 | 30,096 | $2.53M |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 5.6% | 63,367 | 52,258 | $1.78M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.4% | 18,068 | 16,078 | $1.39M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.4% | 12,738 | 11,658 | $1.08M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.2% | 29,894 | 25,605 | $998K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 12,362 | 10,814 | $469K |
| 96161 | 1.3% | 24,736 | 20,932 | $419K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.0% | 3,855 | 3,484 | $327K |
79 more codes
| 92551 | 1.0% | 40,512 | $321K | |
| 99177 | <1% | 41,380 | $310K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 8,776 | $284K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 31,104 | $260K |
| 80061 | Lipid panel | <1% | 6,339 | $107K |
| 96127 | <1% | 24,742 | $106K | |
| 99381 | <1% | 1,066 | $83K | |
| 99173 | <1% | 14,479 | $79K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,314 | $76K |
| 36416 | <1% | 40,600 | $70K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,643 | $56K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,785 | $40K |
| 87807 | <1% | 2,743 | $30K | |
| 90670 | <1% | 19,188 | $25K | |
| 99460 | <1% | 418 | $19K | |
| 86738 | <1% | 1,463 | $17K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,410 | $17K |
| 83655 | <1% | 1,237 | $17K | |
| 81003 | <1% | 8,024 | $17K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 150 | $12K |
| 90686 | <1% | 19,618 | $11K | |
| 99383 | <1% | 112 | $10K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 411 | $8K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 105 | $7K |
| 99382 | <1% | 83 | $7K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 149 | $7K |
| 92567 | <1% | 457 | $7K | |
| 90723 | <1% | 13,689 | $6K | |
| 90680 | <1% | 12,191 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,967 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 338 | $5K |
| 90677 | <1% | 4,631 | $4K | |
| 87081 | <1% | 1,542 | $4K | |
| 90651 | <1% | 383 | $3K | |
| 88720 | <1% | 558 | $3K | |
| 54150 | <1% | 17 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,158 | $3K |
| 69210 | <1% | 55 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 187 | $2K |
| 90647 | <1% | 11,936 | $2K | |
| 85018 | <1% | 727 | $2K | |
| 90633 | <1% | 4,845 | $2K | |
| 0072A | <1% | 37 | $1K | |
| 90716 | <1% | 976 | $1K | |
| 82247 | <1% | 224 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 105 | $1K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 15 | $969.33 |
| 90697 | <1% | 828 | $831.35 | |
| 90707 | <1% | 981 | $766.04 | |
| 85027 | <1% | 116 | $739.09 | |
| 90656 | <1% | 1,043 | $503.52 | |
| 90620 | <1% | 18 | $498.81 | |
| 90671 | <1% | 390 | $488.18 | |
| 82465 | <1% | 233 | $404.31 | |
| 81001 | <1% | 115 | $374.08 | |
| 96380 | <1% | 13 | $240.58 | |
| 90734 | <1% | 179 | $182.81 | |
| 90661 | <1% | 1,486 | $151.73 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 157 | $144.12 |
| 90696 | <1% | 106 | $129.65 | |
| 90674 | <1% | 913 | $117.63 | |
| 90648 | <1% | 1,242 | $102.06 | |
| 90700 | <1% | 329 | $68.12 | |
| 99051 | <1% | 14 | $51.45 | |
| 82947 | <1% | 12 | $47.45 | |
| 90688 | <1% | 153 | $20.85 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 32 | $5.85 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 67 | $3.68 |
| 90710 | 0% | 71 | $0.00 | |
| 90685 | 0% | 140 | $0.00 | |
| 90681 | 0% | 119 | $0.00 | |
| 90715 | 0% | 31 | $0.00 | |
| E0445 | Oximeter device for measuring blood oxygen levels non-invasively | 0% | 65 | $0.00 |
| 90672 | 0% | 13 | $0.00 | |
| 91300 | 0% | 34 | $0.00 | |
| 3008F | 0% | 59,666 | $0.00 | |
| 91307 | 0% | 77 | $0.00 | |
| 90698 | 0% | 207 | $0.00 | |
| 90744 | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROSENDAHL, ANDREW (CHIEF FINANCIAL OFFICER)
Parent organizationEAST TENNESSEE CHILDREN'S HOSPITAL PRIMARY CARE CENTER INC.
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.